Scalper1 News
Medical-related industry groups were on a tear in the first quarter but have run into some trouble in recent days. Biogen (BIIB) is a good example of what’s been happening. It’s been a leader in the biotech industry and performed well in Q1. It gapped to an all-time high March 20. News of a promising treatment for Alzheimer’s fueled the advance. Since then, it’s given up all that gain and more and is trading 13% off its high. Volume was well Scalper1 News
Scalper1 News